News Focus
News Focus
icon url

cheynew

04/19/16 9:37 AM

#262260 RE: cjgaddy #262258

This quote reminds me of King stating multiple times that the pps will take care of itself.

"Like many small biopharmaceutical companies with a promising pipeline product, Peregrine chooses to emphasize clinical development over manufacturing or process development, confident that if bavituximab succeeds in the clinic, then CoG issues will resolve themselves. "
icon url

J.Lummouxx

04/21/16 12:57 PM

#262479 RE: cjgaddy #262258

Interesting bio on the writer, Stony Brook, and Brookhaven Lab. Why or how would he know to interview King?